Article Text

Download PDFPDF
EAHP Survey 2010 on hospital pharmacy in Europe: Part 3. Production and quality assurance
  1. R Frontini1,2,
  2. T Miharija-Gala1,3,
  3. J Sykora1,4
  1. 1European Association of Hospital Pharmacists, Brussels, Belgium
  2. 2Universitätsklinikum Leipzig, Leipzig, Germany
  3. 3University Medical Centre Ljubljana, Ljubljana, Slovenia
  4. 4National Cancer Institute and Slovak Medical School, Bratislava, Slovakia;
  1. Correspondence to Dr Roberto Frontini, Universitätsklinikum Leipzig, Liebigstr. 20, D-04103 Leipzig, Germany; president{at}


The number of hospital pharmacies in Europe producing sterile as well as non-sterile medicines has decreased significantly since 2000. In addition, the number of pharmacies preparing total parenteral nutrition, cytotoxics and intravenous admixtures (24.6%, 43.8% and 8.0% of pharmacies, respectively) is quite low and depends to a large extent on the size of the pharmacies, with larger units generally demonstrating significantly higher production activity. There are some differences between eastern and western Europe. Quality control and good manufacturing practice (GMP) seem to be well implemented (61.3% of pharmacies have adopted GMP) and many pharmacies have external certification.

  • Pharmacy Management (Organisation, Financial)
  • Pharmacotherapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.